The World Health Organization has been monitoring the impact of the novel coronavirus on the global supply of active pharmaceutical ingredients , Dr . Mike Ryan , executive director of the World Health Organization ’s Health Emergencies Programme , said today during a press briefing , and it is concerned . 
" We do believe , though , with the decreasing incidence in China , that many companies who do produce these APIs are beginning to come back online , " Ryan said . 
The US Food and Drug Administration announced Thursday the country ’s first novel coronavirus related drug shortage . 
The maker of an unnamed drug that has recently been added to the FDA Drug Shortages list told the agency that the shortage is due to the novel coronavirus . 
Earlier in the week , the agency said it had identified 20 drugs that either solely sourced their active pharmaceutical ingredients , or produced finished drug products , from or in China . 
